CD39/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with Sezary syndrome

被引：5
|
作者：
Yakymiv, Yuliya [1 ]
Marchisio, Sara [1 ]
Ortolan, Erika [1 ]
Bracci, Cristiano [1 ]
Senetta, Rebecca [2 ]
Rumore, Maria Rebecca [2 ]
Tampieri, Cristian [3 ]
Fia, Marianna [4 ]
Ribero, Simone [4 ]
Funaro, Ada [1 ,5 ]
Quaglino, Pietro [1 ,6 ]
机构：
[1] Univ Turin, Dept Med Sci, Lab Immunogenet, Turin, Italy
[2] Univ Turin, Dept Oncol, Pathol Unit, Turin, Italy
[3] Univ Turin, Dept Med Sci, Pathol Unit, Turin, Italy
[4] Univ Turin, Dept Med Sci, Dermatol Clin, Turin, Italy
[5] Univ Turin, Lab Immunogenet, Dept Med Sci, Via Santena 19, I-10126 Turin, Italy
[6] Univ Turin, Dept Med Sci, Dermatol Clin, Via Cherasco 23, I-10121 Turin, Italy
来源：
BLOOD | 2023年 / 141卷 / 01期
关键词：
FLOW-CYTOMETRY; CD39; IDENTIFICATION; PROLIFERATION; ACTIVATION; PATHWAY; BLOOD;
D O I：
10.1182/blood.2022017259
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：111 / 116
页数：6
相关论文
共 50 条
  • [41] Role of ectoenzymes CD39 and CD73 in the immune response to multiple myeloma
    Yang, Rui
    Elsaadi, Samah
    Misund, Kristine
    Slupphaug, Geir
    Menu, Eline
    Hay, Carl
    Cooper, Zac
    Vanderkerken, Karin
    Borset, Magne
    Sponaas, Anne Marit
    CANCER RESEARCH, 2018, 78 (13)
  • [42] CD39/CD73/A2AR pathway and cancer immunotherapy
    Xia, Chenglai
    Yin, Shuanghong
    To, Kenneth K. W.
    Fu, Liwu
    MOLECULAR CANCER, 2023, 22 (01)
  • [43] CD39/CD73 Expressing Exosomes Protect Against Arterial Thrombosis
    Covarrubias, Roman
    Snoek, Susanne A.
    Zhong, Lin
    Broekstra, Niels
    Finn, Jonathan D.
    Gumina, Richard J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [44] CD39/CD73/A2AR pathway and cancer immunotherapy
    Chenglai Xia
    Shuanghong Yin
    Kenneth K. W. To
    Liwu Fu
    Molecular Cancer, 22
  • [45] CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
    Battastini, Ana Maria Oliveira
    Figueiro, Fabricio
    Leal, Daniela Bitencourt Rosa
    Doleski, Pedro Henrique
    Schetinger, Maria Rosa Chitolina
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [46] CD71+erythroid cells promote Tregs and via ectonucleotides CD39 and CD73 modulate T cell responses
    Elahi, Shokrollah
    Shahbaz, Shima
    Koleva, Petya
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [47] The role of Ectonucleotidases Pathway (CD39/CD73) in Childhood Renal Failure
    Abd-Elaziz, Nahla M.
    Ateya, Ateyat A.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (04): : 2135 - 2140
  • [48] Tumor resident Treg degrade ATP to adenosine via CD39/CD73, resulting in downregulation of CD69 on effector T cells
    Kretz, M.
    Ring, S.
    Enk, A. H.
    Mahnke, K.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 187 - 187
  • [49] Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity
    Dorneles, Gilson P.
    Teixeira, Paula C.
    da Silva, Igor M.
    Schipper, Lucas L.
    Santana Filho, Paulo C.
    Rodrigues Junior, Luiz C.
    Bonorino, Cristina
    Peres, Alessandra
    Fonseca, Simone G.
    Monteiro, Marta C.
    Boeck, Carina R.
    Eller, Sarah
    Oliveira, Tiago F.
    Wendland, Eliana M.
    Romao, Pedro R. T.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (08) : 3394 - 3407
  • [50] Novel Evidence That the Ectonucleotidases CD39 and CD73, Which Are Expressed on Hematopoietic Stem/Progenitor Cells (HSPCs), Regulate Mobilization and Homing - Studies in CD39-/- and CD73-/- Mice and with Small-Molecule CD39 and CD73 Inhibitors
    Adamiak, Mateusz
    Bujko, Kamila
    Lenkiewicz, Anna
    Kucia, Magdalena
    Ratajczak, Janina
    Ratajczak, Mariusz Z.
    BLOOD, 2018, 132
12345